Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
18.8%
% of WDNA's 90 holdings also in BBH
64.0%
% of BBH's 27 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus BBH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in BBH |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 4.0% | 4.9% | 4.0% |
|
SAREPTA THERAPEUTICS INC | 1.6% | 2.3% | 1.6% |
|
ALNYLAM PHARMACEUTICALS INC | 1.5% | 3.8% | 1.5% |
|
VERTEX PHARMACEUTICALS INC | 1.4% | 10.5% | 1.4% |
|
GILEAD SCIENCES INC | 1.4% | 11.3% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to BBH
|
TWIST BIOSCIENCE CORP. | 3.8% |
 |
NOVOZYMES A/S-B SHARES | 3.5% |
|
VERICEL CORPORATION | 2.8% |
|
BLUEPRINT MEDICINES CORP. | 2.5% |
|
VERACYTE INC | 2.5% |
|
ELI LILLY & CO | 2.3% |
|
GERON CORP | 2.1% |
|
BRIDGEBIO PHARMA, INC. | 2.0% |
|
AGIOS PHARMACEUTICALS INC | 1.9% |
|
UNITED THERAPEUTICS CORP | 1.8% |
WDNA Underweight Relative to BBH
|
AMGEN INC | -14.1% |
|
GILEAD SCIENCES INC | -9.8% |
|
VERTEX PHARMACEUTICALS INC | -9.0% |
|
REGENERON PHARMACEUTICALS | -5.3% |
|
IQVIA HOLDINGS INC | -4.7% |
 |
ARGENX SE ADR | -4.7% |
 |
ICON PLC | -3.7% |
|
ILLUMINA INC | -3.1% |
|
NEUROCRINE BIOSCIENCES INC | -2.7% |
|
BIOGEN IDEC INC | -2.6% |